Nutritional compositions with coated lipid globules
First Claim
Patent Images
1. A method of increasing bone mass density and/or increasing bone mineral content, comprising administering to a human subject between 0 and 36 months of age at risk of developing osteoporosis or in need of enhancement of bone formation and/or bone mass maximation, a composition comprising:
- (a) 10 to 50 wt. % of vegetable lipids, based on dry weight of the composition,(b) 1.0 to 10 wt. % of phospholipids, based on total lipid,(c) glycosphingolipids, and(d) cholesterol,wherein the lipids comprise at least 16 wt. % palmitic acid based on total fatty acids of the composition, andwherein the vegetable lipids and the phospholipids are in lipid globules with a core comprising said vegetable lipids and a coating comprising said phospholipids lipids.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a lipid globules coated with phospholipids. The composition is used for increasing bone mineral content, bone mineral density, preventing osteoporosis, and/or preventing ostopenia.
-
Citations
17 Claims
-
1. A method of increasing bone mass density and/or increasing bone mineral content, comprising administering to a human subject between 0 and 36 months of age at risk of developing osteoporosis or in need of enhancement of bone formation and/or bone mass maximation, a composition comprising:
-
(a) 10 to 50 wt. % of vegetable lipids, based on dry weight of the composition, (b) 1.0 to 10 wt. % of phospholipids, based on total lipid, (c) glycosphingolipids, and (d) cholesterol, wherein the lipids comprise at least 16 wt. % palmitic acid based on total fatty acids of the composition, and wherein the vegetable lipids and the phospholipids are in lipid globules with a core comprising said vegetable lipids and a coating comprising said phospholipids lipids. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 15, 16, 17)
-
-
12. A method of treating and/or preventing osteoporosis and/or osteopenia, comprising administering to a human subject between 0 and 36 months of age at risk of developing osteoporosis and/or ostopenia a composition comprising:
-
(a) 10 to 50 wt. % of vegetable lipids, based on dry weight of the composition, (b) 1.0 to 10 wt. % of phospholipids, based on total lipid, (c) glycosphingolipids, and (d) cholesterol, wherein the lipids comprise at least 16 wt. % palmitic acid based on total fatty acids of the composition, and wherein the vegetable lipids and the phospholipids are in lipid globules with a core comprising said vegetable lipids and a coating comprising said phospholipids. - View Dependent Claims (13, 14)
-
Specification